Skip to main content
NASDAQ:GERN

Geron News Headlines

$1.43
+0.09 (+6.72 %)
(As of 05/14/2021 12:06 PM ET)
Add
Compare
Today's Range
$1.35
$1.43
50-Day Range
$1.25
$1.62
52-Week Range
$1.22
$2.40
Volume12,596 shs
Average Volume3.30 million shs
Market Capitalization$455.55 million
P/E RatioN/A
Dividend YieldN/A
Beta1.5

Headlines

Geron (NASDAQ GERN) News Headlines Today

SourceHeadline
Geron Co. Expected to Earn Q2 2021 Earnings of ($0.09) Per Share (NASDAQ:GERN)Geron Co. Expected to Earn Q2 2021 Earnings of ($0.09) Per Share (NASDAQ:GERN)
americanbankingnews.com - May 14 at 8:56 AM
Geron Co. (NASDAQ:GERN) Expected to Announce Quarterly Sales of $80,000.00Geron Co. (NASDAQ:GERN) Expected to Announce Quarterly Sales of $80,000.00
americanbankingnews.com - May 14 at 1:22 AM
Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress - Business WireGeron Announces Two Presentations at Upcoming European Hematology Association Annual Congress - Business Wire
businesswire.com - May 13 at 3:33 AM
Geron Co. (NASDAQ:GERN) Expected to Post Earnings of -$0.08 Per ShareGeron Co. (NASDAQ:GERN) Expected to Post Earnings of -$0.08 Per Share
americanbankingnews.com - May 12 at 7:18 PM
Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress - Yahoo FinanceGeron Announces Two Presentations at Upcoming European Hematology Association Annual Congress - Yahoo Finance
finance.yahoo.com - May 12 at 5:17 PM
Geron Announces Two Presentations at Upcoming European Hematology Association Annual CongressGeron Announces Two Presentations at Upcoming European Hematology Association Annual Congress
finance.yahoo.com - May 12 at 12:15 PM
Geron (GERN) Q1 2021 Earnings Call Transcript - Motley FoolGeron (GERN) Q1 2021 Earnings Call Transcript - Motley Fool
fool.com - May 11 at 12:54 PM
Geron (NASDAQ:GERN) Announces  Earnings Results, Misses Expectations By $0.01 EPSGeron (NASDAQ:GERN) Announces Earnings Results, Misses Expectations By $0.01 EPS
americanbankingnews.com - May 11 at 12:34 PM
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo FinanceGeron (GERN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 11 at 7:54 AM
Geron (GERN) Q1 2021 Earnings Call TranscriptGeron (GERN) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 11 at 7:54 AM
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates - NasdaqGeron (GERN) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
nasdaq.com - May 10 at 7:15 PM
Geron: Q1 Earnings Insights - BenzingaGeron: Q1 Earnings Insights - Benzinga
benzinga.com - May 10 at 7:15 PM
Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights - Business WireGeron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights - Business Wire
businesswire.com - May 10 at 7:15 PM
Geron (GERN) Reports Q1 Loss, Tops Revenue EstimatesGeron (GERN) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 10 at 7:15 PM
Washington will host LT Charles Leno Jr. for a free agent visit on Monday - Reverb MSN MusicWashington will host LT Charles Leno Jr. for a free agent visit on Monday - Reverb MSN Music
msn.com - May 6 at 7:12 PM
Is RAPT Therapeutics, Inc. (NASDAQ:RAPT) Popular Amongst Institutions? - NasdaqIs RAPT Therapeutics, Inc. (NASDAQ:RAPT) Popular Amongst Institutions? - Nasdaq
nasdaq.com - May 5 at 1:30 AM
Heres Why Its Unlikely That Geron Corporations (NASDAQ:GERN) CEO Will See A Pay Rise This Year - Yahoo FinanceHere's Why It's Unlikely That Geron Corporation's (NASDAQ:GERN) CEO Will See A Pay Rise This Year - Yahoo Finance
finance.yahoo.com - May 4 at 8:26 PM
Heres Why Its Unlikely That Geron Corporations (NASDAQ:GERN) CEO Will See A Pay Rise This YearHere's Why It's Unlikely That Geron Corporation's (NASDAQ:GERN) CEO Will See A Pay Rise This Year
finance.yahoo.com - May 4 at 8:26 PM
Geron (GERN) to Release Earnings on MondayGeron (GERN) to Release Earnings on Monday
americanbankingnews.com - May 4 at 12:20 PM
Geron to Announce First Quarter 2021 Financial Results on May 10, 2021 - Business WireGeron to Announce First Quarter 2021 Financial Results on May 10, 2021 - Business Wire
businesswire.com - May 3 at 6:53 PM
Geron to Announce First Quarter 2021 Financial Results on May 10, 2021Geron to Announce First Quarter 2021 Financial Results on May 10, 2021
finance.yahoo.com - May 3 at 6:53 PM
Why I like the decision to draft Sam Cosmi as Washingtons future left tackle - Reverb MSN MusicWhy I like the decision to draft Sam Cosmi as Washington's future left tackle - Reverb MSN Music
msn.com - May 3 at 1:52 PM
Geron Co. (NASDAQ:GERN) Receives Average Rating of "Buy" from BrokeragesGeron Co. (NASDAQ:GERN) Receives Average Rating of "Buy" from Brokerages
americanbankingnews.com - April 30 at 6:34 AM
SHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the Firm - Yahoo FinanceSHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the Firm - Yahoo Finance
finance.yahoo.com - April 28 at 11:48 AM
SHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the Firm - GlobeNewswireSHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the Firm - GlobeNewswire
globenewswire.com - April 27 at 7:49 AM
SHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the FirmSHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the Firm
finance.yahoo.com - April 27 at 7:49 AM
$80,000.00 in Sales Expected for Geron Co. (NASDAQ:GERN) This Quarter$80,000.00 in Sales Expected for Geron Co. (NASDAQ:GERN) This Quarter
americanbankingnews.com - April 27 at 5:44 AM
 Analysts Expect Geron Co. (NASDAQ:GERN) to Announce -$0.08 Earnings Per Share Analysts Expect Geron Co. (NASDAQ:GERN) to Announce -$0.08 Earnings Per Share
americanbankingnews.com - April 25 at 2:08 AM
Spinal Cord Injury Clinical Trials Review: A Multitude of Emerging Drugs for Better Treatment - GlobeNewswireSpinal Cord Injury Clinical Trials Review: A Multitude of Emerging Drugs for Better Treatment - GlobeNewswire
globenewswire.com - April 21 at 10:48 PM
GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, PC - GlobeNewswireGERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, PC - GlobeNewswire
globenewswire.com - April 21 at 10:48 PM
GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C. - Yahoo FinanceGERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C. - Yahoo Finance
finance.yahoo.com - April 20 at 8:12 PM
GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C.GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C.
finance.yahoo.com - April 20 at 8:11 PM
What Kind Of Shareholders Hold The Majority In Geron Corporations (NASDAQ:GERN) Shares? - NasdaqWhat Kind Of Shareholders Hold The Majority In Geron Corporation's (NASDAQ:GERN) Shares? - Nasdaq
nasdaq.com - April 19 at 11:14 PM
If You Had Bought Guaranty Federal Bancshares (NASDAQ:GFED) Shares A Year Ago Youd Have Earned 82% Returns - NasdaqIf You Had Bought Guaranty Federal Bancshares (NASDAQ:GFED) Shares A Year Ago You'd Have Earned 82% Returns - Nasdaq
nasdaq.com - April 19 at 6:13 PM
Lifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL) - Yahoo FinanceLifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL) - Yahoo Finance
finance.yahoo.com - April 19 at 1:11 PM
SHAREHOLDER ALERT: Geron Corporation (GERN) Officers and Directors Under Investigation for False Statements and Insider TradingSHAREHOLDER ALERT: Geron Corporation (GERN) Officers and Directors Under Investigation for False Statements and Insider Trading
finance.yahoo.com - April 19 at 1:11 PM
Britain stands in full support of Czechs after Russian expulsions - ReutersBritain stands in 'full support' of Czechs after Russian expulsions - Reuters
reuters.com - April 18 at 9:38 AM
Lifshitz Law Firm, PC Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL) - GlobeNewswireLifshitz Law Firm, PC Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL) - GlobeNewswire
globenewswire.com - April 18 at 9:38 AM
Lifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL)Lifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL)
finance.yahoo.com - April 18 at 9:38 AM
Blinken says U.S. imposing visa restrictions on those who undermined Ugandan elections - ReutersBlinken says U.S. imposing visa restrictions on those who undermined Ugandan elections - Reuters
reuters.com - April 16 at 9:29 AM
Is Brunswick (BC) a Great Value Stock Right Now? - NasdaqIs Brunswick (BC) a Great Value Stock Right Now? - Nasdaq
nasdaq.com - April 14 at 9:02 PM
Heres Why You Should Hold on to NEOGEN (NEOG) Stock for Now - NasdaqHere's Why You Should Hold on to NEOGEN (NEOG) Stock for Now - Nasdaq
nasdaq.com - April 14 at 9:02 PM
Is J&Js COVID-19 Vaccine Setback a Boon for Other Players? - NasdaqIs J&J's COVID-19 Vaccine Setback a Boon for Other Players? - Nasdaq
nasdaq.com - April 14 at 11:00 AM
Philip Morris (PM) Queued for Q1 Earnings: Factors to Watch - NasdaqPhilip Morris (PM) Queued for Q1 Earnings: Factors to Watch - Nasdaq
nasdaq.com - April 14 at 11:00 AM
Infosys (INFY) Q4 Earnings Meet Estimates, Revenues Beat - NasdaqInfosys (INFY) Q4 Earnings Meet Estimates, Revenues Beat - Nasdaq
nasdaq.com - April 14 at 11:00 AM
Geron (GERN) Begins Phase III Myelofibrosis Study on Imetelstat - Yahoo FinanceGeron (GERN) Begins Phase III Myelofibrosis Study on Imetelstat - Yahoo Finance
finance.yahoo.com - April 14 at 11:00 AM
Geron (GERN) Begins Phase III Myelofibrosis Study on ImetelstatGeron (GERN) Begins Phase III Myelofibrosis Study on Imetelstat
finance.yahoo.com - April 14 at 11:00 AM
Geron Doses First Patient In IMpactMF Phase 3 Trial In Refractory Myelofibrosis - Quick FactsGeron Doses First Patient In IMpactMF Phase 3 Trial In Refractory Myelofibrosis - Quick Facts
markets.businessinsider.com - April 14 at 6:00 AM
Geron Doses First Patient In IMpactMF Phase 3 Trial In Refractory Myelofibrosis - Quick Facts - NasdaqGeron Doses First Patient In IMpactMF Phase 3 Trial In Refractory Myelofibrosis - Quick Facts - Nasdaq
nasdaq.com - April 13 at 2:56 PM
Geron starts dosing in late-stage blood cancer study - Seeking AlphaGeron starts dosing in late-stage blood cancer study - Seeking Alpha
seekingalpha.com - April 13 at 2:56 PM
This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.